Imugene's drug gets an unusually early tick of approval
Imugene CEO Leslie Chong says the company's cancer drug trial has progressed faster than many even in her own company have expected.
With a low hazard ratio now confirmed for its flagship drug, Chong says the next challenge is deciding what to do!
https://www.******.com.au/media/imugenes-drug-gets-an-unusually-early-tick-of-approval?videoId=5688
GLAH...
Ann: Imugene HER Vaxx shows positive Overall Survival in trial, page-228
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.1¢ |
Change
-0.003(6.82%) |
Mkt cap ! $304.9M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.1¢ | $1.607M | 38.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 23 | 4542680 | 4.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.3¢ | 1675759 | 9 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |